Phase III study of combined chemohormonal therapy in metastatic prostate cancer (ECOG 3882): an Eastern Cooperative Oncology Group study. [electronic resource]
Producer: 20031209Description: 137-46 p. digitalISSN:- 1357-0560
- Aged
- Antibiotics, Antineoplastic -- administration & dosage
- Antineoplastic Agents, Hormonal -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Diethylstilbestrol -- adverse effects
- Doxorubicin -- administration & dosage
- Humans
- Male
- Middle Aged
- Prostatic Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.